Concepedia

Enhanced secretion of glucagon-like peptide 1 by biguanide compounds

Nobuyuki Yasuda, Takashi Inoue, Tadashi Nagakura, Kazuto Yamazaki, Kazunobu Kira, T. Saeki, Isao Tanaka

Biochemical and Biophysical Research Communications · 2002 · 138 citations · 16 references

DOI

Concepts

References

16

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

Mette Zander, Sten Madsbad, Jan Lysgaard Madsen et al. · The Lancet · 2002 · 1.3K citations

, , +16

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients

Michael A. Nauck, N. Kleine, C. �rskov et al. · Diabetologia · 1993 · 1.1K citations · Full text

, , +15

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus

M. Gutniak, Jens J. Holst, Bo Åhrén et al. · New England Journal of Medicine · 1992 · 875 citations · Full text

, , +17

Effect of Metformin on Glucagon-Like Peptide 1 (GLP-1) and Leptin Levels in Obese Nondiabetic Subjects

Edoardo Mannucci, Agostino Ognibene, Francesco Cremasco et al. · Diabetes Care · 2001 · 298 citations · Full text

, , +16

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

David A. D’Alessio, Steven E. Kahn, C R Leusner et al. · Journal of Clinical Investigation · 1994 · 283 citations · Full text

, , +15